Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 02 - 25 tags : Disease save search
Biolojic Design Enters a Research Collaboration and License Option Agreement with Nektar Therapeutics to Develop Computationally Designed Antibodies Against a Novel Target for the Potential Treatment of Autoimmune Disease
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
NKTR | News | $1.35 -9.4% -10.78% 5.9K
|
Health Technology
|
| O: 0.04%
H: 1.36%
C: -1.49%
disease treatment collaboration computational license research antibody potential designation
Akari Therapeutics Presents New Preclinical Data Highlighting Potential of Long-Acting PASylated Nomacopan to Treat Retinal Diseases, Including Age-Related Macular Degeneration (AMD) and Uveitis
Published: 2021-02-25 (Crawled : 15:00) - biospace.com/
AKTX | $1.1212 -2.97% -1.69% 0
|
Health Technology
|
| O: 2.31%
H: 1.69%
C: -6.21%
disease retina macular potential dmd preclinical pre-clinical
Travere Therapeutics Recognizes Rare Disease Day 2021 and the Importance of Working Together to Innovate and Address Healthcare Disparities in Rare Disease
Published: 2021-02-25 (Crawled : 13:05) - globenewswire.com
TVTX | $5.92 -1.17% 8.2K
|
Health Technology
|
| O: 0.27%
H: 2.63%
C: -1.1%
disease rare
Gainers vs Losers
| 46% | 54% |
Top 10 Gainers
AGBA | $1.44 260.0% 40M
|
Finance
BPTH | $6.25 92.9% 20M
|
Health Technology
BNTC | $5.91 23.13% 1.3M
|
Health Technology
XPON | $2.33 20.73% 410K
|
BRSH | $0.0515 15.99% 12M
|
n/a
VTNR S | $1.12 14.38% 470K
|
Industrial Services
DXYZ 4 | $33.49 13.41% 210K
|
n/a
BMI 4 | $169.84 11.01% 68K
|
Producer Manufacturing
CTM | $0.244 10.86% 40K
|
n/a
DXF | $0.2999 10.75% 150K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.